Literature DB >> 12122393

Illness representations and coping of women with chronic obstructive pulmonary disease: a pilot study.

Eileen S O'Neill1.   

Abstract

OBJECTIVE: The purpose of this study was to explore how women recognize and respond to symptoms of chronic obstructive pulmonary disease (COPD). FRAMEWORK: The Common Sense Model by Leventhal provided the theoretic framework for the study.
DESIGN: A descriptive qualitative design was used. SAMPLE: The study sample included 21 women enrolled in pulmonary rehabilitation programs.
FINDINGS: The causes and consequences of COPD were these women's most prominent representations. They struggled not only with dyspnea and fatigue, but with depression, loss of social support and intimacy, and stigma. Breathing techniques, medication, rest, and avoidance measures were the most frequently used coping strategies. PRACTICE IMPLICATIONS: Because dyspnea is the central symptom, nurses must continue to teach methods to control it, as well as to search for new interventions to relieve the symptoms. Optimal levels of rest and the effect on outcomes deserve close attention. Devising ways to deal with social and psychologic isolation would also enhance coping with COPD.

Entities:  

Mesh:

Year:  2002        PMID: 12122393     DOI: 10.1067/mhl.2002.123712

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  10 in total

1.  Relationship between illness perceptions, treatment adherence, and clinical outcomes in patients on maintenance hemodialysis.

Authors:  Youngmee Kim; Lorraine S Evangelista
Journal:  Nephrol Nurs J       Date:  2010 May-Jun       Impact factor: 0.959

Review 2.  Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature.

Authors:  M Giacomini; D DeJean; D Simeonov; A Smith
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

3.  Behavioral and characterological self-blame in chronic obstructive pulmonary disease.

Authors:  Melissa R Plaufcan; Frederick S Wamboldt; Kristen E Holm
Journal:  J Psychosom Res       Date:  2011-12-07       Impact factor: 3.006

4.  Smoking-Related Stigma Expressed by Physiotherapists toward Individuals with Lung Disease.

Authors:  Bethany Bass; Elizabeth Lake; Chelsea Elvy; Sarah Fodemesi; Mara Iacoe; Emilie Mazik; Dina Brooks; Annemarie Lee
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

5.  Illness representations of chronic obstructive pulmonary disease (COPD) to inform health education strategies and research design-learning from rural Uganda.

Authors:  Emily M Nagourney; Nicole M Robertson; Natalie Rykiel; Trishul Siddharthan; Patricia Alupo; Marysol Encarnacion; Bruce J Kirenga; Robert Kalyesubula; Shumonta A Quaderi; John R Hurst; William Checkley; Suzanne L Pollard
Journal:  Health Educ Res       Date:  2020-08-01

6.  The experience of stigma in chronic obstructive pulmonary disease.

Authors:  Barbara E Berger; Mary C Kapella; Janet L Larson
Journal:  West J Nurs Res       Date:  2010-10-12       Impact factor: 1.967

7.  'Belonging'. 'Patients' experiences of social relationships during pulmonary rehabilitation.

Authors:  Anne-Grethe Halding; Astrid Wahl; Kristin Heggdal
Journal:  Disabil Rehabil       Date:  2010       Impact factor: 3.033

8.  A qualitative study of women's experiences of living with COPD.

Authors:  Simen A Steindal; Jane Österlind; Kristin Halvorsen; Therese Schjelderup; Ellen Kive; Liv Wergeland Sørbye; Alfhild Dihle
Journal:  Nurs Open       Date:  2017-05-16

Review 9.  Sexual Health in COPD: A Systematic Review and Meta-Analysis.

Authors:  Ingeborg Farver-Vestergaard; Yoon Frederiksen; Robert Zachariae; Sandra Rubio-Rask; Anders Løkke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-09

10.  Sexual health communication in COPD: The role, contents and design of patient information leaflets.

Authors:  Sandra Esperanza Rubio-Rask; Ingeborg Farver-Vestergaard; Ole Hilberg; Anders Løkke
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.